In view of FA patient’s hypersensitivity to chemotherapeutic agents and the occurrence of cancer types often associated with high STMN1 activity, anti-STMN1 therapy may provide an alternative cancer treatment option for FA patients. The gene discussed is STMN1; the disease is cancer.